PV25 Speakers

Subject to change.

 

 

image

Michele Mitchell, BS, MS, PMP

Patient Advocate, American Society for Clinical Pathologist


Breast cancer survivor & Patient Advocate-Michele co-chairs the UofM Dept of Pathology PFAC, serves as an advisor to the American Society for Clinical Pathologist, ACS, DPA Patient Engagement Council, MyPathologyReport.ca website, MI Hosp Assoc, MI Cancer Consortium. She champions digital pathology, AI, health equity & clinical trial access. She is dedicated to advancing patient-centered care ensuring the patient voice shapes healthcare policy and practice at local, state, and national levels.

 

 

SESSIONS

Digital Pathology & Patient Impact: The Michigan Medicine Pathology Clinic Experience
   Mon, Oct 6
   12:45PM - 01:05PM PT
  Seaport Ballroom F

This presentation, co-developed by Michele Mitchell (Patient Advocate), Dr. Rouba Ali-Fehmi, MD (Professor and Medical Director of Breast Pathology), and Dr. Mustafa Qays Yousif, MD (Director of Digital Pathology, Department of Pathology, and Clinical Assistant Professor of Breast Pathology), explores how digital pathology is transforming patient education and empowerment at Michigan Medicine. It centers on the Breast Pathology Consultation Program-an initiative that uses digital tools to enhance understanding, support shared decision-making, and promote patient engagement.The session highlights the perspective of a breast cancer survivor and advocate. Diagnosed in 2006 with Stage 1A Invasive Ductal Carcinoma (ER/PR-positive, HER2-negative), Michele Mitchell underwent surgery, chemotherapy, radiation, and long-term hormonal therapy. Years later, she viewed a digital representation of her own cancer-a moment that clarified the nature of her disease, including tumor grade, and transformed her understanding. This deeply personal experience inspired her commitment to advancing patient access to diagnostic tools and the power of digital pathology.Mitchell now serves as Co-Chair of the Michigan Medicine Department of Pathology Patient and Family Advisory Council (PFAC), which formally recommended the development of the Breast Pathology Consultation Program in 2023. She also advises several institutional and national efforts aimed at improving transparency, trust, and engagement in healthcare.Dr. Ali-Fehmi and Dr. Yousif will detail how digital pathology is used in the Breast Pathology Consultation Clinic, which has supported more than 120 patients in understanding their disease and engaging more confidently in their care. They will discuss how digitized pathology images and patient-pathologist dialogue improve comprehension and decision-making, helping to bridge the gap between diagnosis and treatment.This presentation will demonstrate the role of digital pathology as a tool to empower patients, personalize care, and improve patient-provider communication. Together, the presenters will showcase a model of innovation and collaboration that may be replicable at other institutions.

 

Learning Objectives: 

  1. Understand how exploring digital pathology can enhance patient education and empowerment, as evidenced by the 120+ patients who have benefited from Michigan Medicine's Breast Pathology Consultation Program.
  2. Recognize the impact of viewing digital pathology slides combined with an explanation from the diagnosing pathologist on patient understanding and treatment decisions.
  3. Learn how improved patient-pathologist interactions can enhance trust, adherence to treatment plans, and overall patient outcomes.

 

Pathology in the Digital Age: Empowering Patient Engagement
   Tue, Oct 7
   10:00AM - 11:00AM PT
  Seaport Ballroom A

Digital pathology offers more than technological progress—it creates opportunities to bring patients closer to their diagnoses and strengthen the role of pathology in patient care. This session marks the first public program of the Digital Pathology Association’s Patient Engagement Committee, formed to advance best practices for involving patients and the public in digital pathology.

Speakers will share perspectives from a patient, leaders in patient and public involvement, and pathologists committed to patient-centered digital pathology practice. Together, they will demonstrate how direct visualization of pathology digital images, co-created educational resources, and clear communication of diagnostic information enhanced via the digital slide can empower patients to better understand their conditions and participate in care decisions.  The discussion will also highlight how these approaches provide unique opportunities for health systems to differentiate themselves, foster trust and improve patient and family support, as well as highlighting hidden benefits on the investment in digital pathology.

Chat bot